KLOW 80mg

KLOW Blend (80mg)

KLOW is a 4-in-1 regenerative peptide blend combining four well-researched compounds — GHK-Cu, BPC-157, TB-500, and KPV — into a single high-dose formulation. Commonly referred to as a "Radiance Recovery" or "Wolverine" stack, it is designed to target musculoskeletal healing, gut repair, skin rejuvenation, and systemic inflammation reduction. Each component works via distinct but complementary mechanisms, making KLOW a broadly studied blend in regenerative research.

Blend Composition

• GHK-Cu — 50mg | Copper peptide; collagen synthesis, skin repair, antioxidant activity
• BPC-157 — 10mg | Tissue repair, tendon and ligament healing, gut lining support
• TB-500 — 10mg | Actin polymerization, muscle repair, cellular motility, angiogenesis
• KPV — 10mg | Anti-inflammatory tripeptide; immune modulation and gut health

Research Highlights

• Musculoskeletal Repair — BPC-157 and TB-500 have independently shown potential in accelerating recovery of tendons, ligaments, and muscle tissue in murine models, with TB-500 supporting collagen organization and BPC-157 promoting fibroblast migration and angiogenesis.
• Skin & Collagen Regeneration — GHK-Cu's well-documented role in stimulating collagen synthesis, tissue inhibitor production, and extracellular matrix support forms the foundation of KLOW's reported "glow" factor — with research suggesting potential reversal of skin thinning and improved wound closure rates.
• Anti-Inflammatory Action — KPV, a tripeptide derived from alpha-MSH, has been studied for its ability to reduce pro-inflammatory cytokine activity and modulate immune response, while GHK-Cu research points to inhibition of NF-κB signaling and reduced oxidative stress markers.
• Gut Health — BPC-157 has been studied for its potential to support repair of the intestinal lining and regulate inflammation within the gastrointestinal tract, complemented by KPV's anti-inflammatory properties in gut tissue research.
• Antioxidant Defense — GHK-Cu research suggests the peptide may neutralize hydroxyl and peroxyl radicals, restrict iron release from ferritin by up to 87%, and activate the Nrf2 oxidative defense pathway — contributing to KLOW's broader cellular protection profile.

Available for research and laboratory purposes only.